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Abstract Septins are a family of cytoskeletal proteins involved
in cytokinesis, targeting of proteins to specific sites on the plasma
membrane, and cellular morphogenesis. While many aspects of
their function in cytokinesis in yeast cells have been investigated,
the function of septins in mammalian cells is less well understood.
For example, septins are present in post-mitotic neurons,
suggesting they have other roles in, for example, establishing
cell polarity. The full extent of the septin gene family is not
known in mammalian cells. To better understand the septin gene
family, we have cloned and characterized a novel mammalian
septin.
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1. Introduction
Septins are a family of cytoskeletal proteins ¢rst identi¢ed
in yeast (reviewed in [1,2]). The septin yeast mutants CDC3,
CDC10, CDC11, and CDC12 demonstrated defects in the cell
division cycle whose phenotype consisted of defects in bud
morphogenesis, cytokinesis and localization of chitin deposi-
tion [3]. The defective chitin deposition seen in the original
mutants has since been traced to the role of septins in the
proper targeting of Chs3p, the catalytic subunit of chitin syn-
thase III, to the ring at the base of the bud [4]. The defective
bud morphogenesis is related to the septins’ role in localizing
membrane proteins such as Bud3p and Bud4p to sites at
which budding should occur [2]. Septin proteins have subse-
quently been found to be present in most cell types of multi-
cellular organisms and appear to play a role in cytokinesis in
these cells. For example, in Drosophila, the septin Pnut local-
izes to cleavage furrows of dividing cells, and £ies de¢cient for
Pnut die as pupae with small imaginal discs [5]. Similar cyto-
kinesis defects have been seen in £ies mutant for a second
Drosophila septin, Sep1 [6]. At the ultrastructural level, septins
localize to a ring of 10 nm ¢laments seen at the bud neck of
dividing yeast cells [7,8]. Septins have been shown in several
systems to associate with each other and to form ¢laments in
vitro [9]
It is likely that the ability of septins to recruit proteins to
speci¢c sites on the plasma membrane during cytokinesis is
important for their participation in processes such as cellular
morphogenesis and the development of cellular polarity. For
example, septins have been implicated in the morphogenetic
response to pheromones in yeast via their interaction with
Afr1p [10]. Septins have also been found in neurons, which
are polarized but mitotically inactive, and their function in
these cells remains to be determined [11]. Recently, it was
found that some septins are associated with the sec 6/8 com-
plex puri¢ed from brain, suggesting a role for these proteins in
the recruitment or docking of vesicles to speci¢c sites on the
plasma membrane [12].
The four original yeast septins were characterized by Prin-
gle and co-workers, and seven mammalian septins have been
characterized. All septins characterized to date contain a P
loop nucleotide binding sequence near the N-terminus as
well as other domains contained in members of the GTPase
superfamily, suggesting that septins may have GTPase cata-
lytic activity. Indeed, several septins have been shown to have
such activity [9] and mutations in the GTP binding site alter
septin localization in mammalian cells [13]. We report here the
characterization of a novel septin that is alternatively spliced.
2. Materials and methods
2.1. Cloning of cDNAs encoding eseptin
mRNA from various rat tissues was puri¢ed using the Qiagen
RNEasy kit. cDNA was synthesized from the mRNA using Moloney
murine leukemia virus reverse transcriptase (Promega) and the cDNA
from brain was used as a template for polymerase chain reaction.
Degenerate oligonucleotides were synthesized and used as primers.
PCR products were cloned into pCR2.1 and sequenced. The clone
encoding a fragment of septin was labeled using the High Prime kit
(Stratagene) and used to screen a lambda-zap rat brain library. For
5P RACE PCR, nested antisense oligonucleotides were synthesized
and used as primers. Marathon cDNA (Clontech) was used as a
template and PCR products were cloned into pCR2.1 and sequenced.
Northern blot analysis was done on a purchased Northern blot
(Clontech) according to the manufacturer’s instructions. Site directed
mutagenesis of the GTP binding site was done using the Quik-Change
protocol (Stratagene).
2.2. GTP binding assay
Glutathione S-transferase fusion proteins of eseptin were expressed
in BL21 or AB1899 cells and puri¢ed according to the manufacturer’s
instructions (Pharmacia). Approximately 2 Wg of fusion protein bound
to glutathione agarose was incubated with binding bu¡er (50 mM Tris
7.4, 2 mM MgCl2, 2 mM DTT, 100 WM ATP, 0.3% Tween) contain-
ing 1 WCi/ml [32P]K-GTP at 4‡C for 1 h. Beads were washed with
binding bu¡er and bound radioactivity was measured by scintillation
counting.
2.3. Tissue culture and immuno£uorescence
COS cells were maintained in DMEM containing 10% fetal bovine
serum with penicillin-streptomycin. Transfection was done using
TransIt reagent (Panvera). Forty-eight hours after transfection, cells
grown on glass coverslips were ¢xed in 4% paraformaldehyde in phos-
phate bu¡ered saline (PBS) for 20 min at room temperature and
permeabilized in 0.5% Triton in PBS. To reduce background, cover-
slips were incubated in 10% normal goat serum in PBS at room
temperature for 1^2 h. Cells were then incubated with a monoclonal
anti-myc antibody (Santa Cruz Biotechnology) diluted in 4% normal
goat serum in PBS at room temperature for 1 h, washed in PBS, and
then incubated with Texas red-conjugated anti-mouse antibody. Cells
were washed in PBS and then mounted using Vectashield.
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Fig. 1. Nucleotide and amino acid sequence of eseptins. The two start methionines are in bold. The peptide sequences from which the pair of
degenerate oligonucleotides were generated are boxed. Underlined are the three consensus sequences for GTP binding. The long form continues
with the start methionine of the short form, and the numbering on the left corresponds to that of the long form, except for the 5P untranslated
region of the short form.
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Fig. 2. Alignment of the eseptins with other mouse septins. The eseptins demonstrate high homology with other mouse septins in their central
portion. Neither eseptin contains a carboxy-terminal extension, while the short eseptin has virtually no N-terminal extension. The GTP binding
motifs are strongly conserved. The asterisk indicates the start methionine of the short eseptin. Dark shading indicates identical residues and
light shading indicates conserved residues.
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3. Results
Immunoprecipitation of the sec 6/8 complex from brain
revealed several associated proteins [12]. Peptide sequencing
of co-immunoprecipitated protein bands led to the identi¢ca-
tion of several septins, including DIFF6, CDC10, H5, and
KIAA0128, that were associated with the sec 6/8 complex.
An additional band of V46 kDa yielded peptides which did
not correspond to any known protein. To characterize this
protein, degenerate oligonucleotides were made to several of
these peptides and used as primers for PCR using rat brain
cDNA as template. Two pairs of oligonucleotides yielded
PCR products with an open reading frame with high homol-
ogy to the known septins. The longer PCR product was used
to screen a recombinant brain cDNA library. Because no
obvious start methionine was present, 5P RACE was per-
formed. Two pools of RACE products with di¡erent 5P
ends were identi¢ed (Figs. 1 and 2). The shorter product con-
tained an in-frame stop codon, but repeated rounds of RACE
failed to identify an in-frame stop codon for the longer prod-
uct. However, the predicted molecular weight of the protein
encoded by the open reading frame is 47 kDa, in agreement
with the size of the protein band from which the novel septin
was cloned. This novel septin was designated eseptin for
eighth septin, since a seventh homolog of septin was recently
identi¢ed [14].
The long form of eseptin is 405 amino acids long while the
short form is 334 amino acids long (Fig. 2). The long form
appears to be an N-terminal extension of the short form, since
it includes the entire coding region of the short form. Analysis
of the primary sequence of eseptin reveals a nucleotide bind-
ing site and additional sequences required for GTPase activity
(underlined in Fig. 1). Much of the central portion of the
protein is conserved with that of other septins, while the ami-
no-terminus is divergent from the hitherto cloned septins.
There is no carboxy-terminal extension containing a predicted
coil-coil domain, as is the case for some septins [1]. No other
functional domains are identi¢ed in the eseptins. A Northern
blot of various rat tissues reveals the presence of the two
forms of eseptin (Fig. 3). These two forms are expressed at
di¡erent ratios in various tissues. For example, testes, kidney,
and liver express almost exclusively the long form. Heart ex-
Fig. 3. Northern blot analysis of rat tissues. A Northern blot con-
taining mRNA from adult rat tissues was probed with the long
form of eseptin. The long eseptin transcript is approximately 4.0 kb
and the short eseptin transcript is approximately 3.7 kb. The North-
ern blot shows a wide distribution of eseptin, although it appears to
be absent from skeletal muscle. The long and short forms are not
expressed at equal levels in all tissues.
Fig. 4. GTP binding of eseptins. Wild type full length eseptins and mutant eseptins (GQSGLGKS was changed to GQSVLGKS) were used in
this assay. Glutathione S-transferase fusion proteins bound to glutathione agarose were incubated with [Q-32P]GTP, washed, and bound radioac-
tivity was assayed by scintillation counting. Data shown are the average of assays done in triplicate.
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presses predominantly the long form, while lung, spleen, and
brain express almost equal amounts of both forms. These
septins do not appear to be expressed in skeletal muscle.
To examine the ability of eseptin to bind GTP, fusion pro-
teins of the short and long forms were incubated with [32P]K-
GTP (Fig. 4). In addition, fusion proteins whose consensus
GTP binding motif GQSGLGKS was mutated to
GQSVLGKS were also tested. Both the long and short forms
of eseptin bound GTP to an equal extent. The mutants did
not bind, as expected.
To examine the subcellular distribution of eseptin, both the
long and short forms were expressed in COS cells with a myc
epitope tag (Fig. 5). While both wild type forms were distrib-
uted to the plasma membrane, the short form also had a more
tubular and vesicular, perinuclear distribution as well. A GTP
binding mutant form of the long eseptin did not have altered
subcellular distribution, but the same mutation in the short
eseptin led to a distinct staining pattern. Eseptin immunoreac-
tivity in cells transfected with the mutant short form of eseptin
was predominantly perinuclear. These results suggest that the
long and short forms of eseptin have di¡erent functions and
that the N-terminal extension of long eseptin may have spe-
ci¢c binding partners that alter its function, stability, or sub-
cellular distribution.
4. Discussion
In this report we describe the cloning of a novel septin.
Eseptin is an alternatively spliced septin that is expressed in
a variety of tissues, although it is notably absent from skeletal
muscle. Like a number of other septins, both forms of eseptin
bind GTP. While both forms are localized to the plasma
membrane, the short form also has a distribution suggestive
of a vesicular membrane compartment, possibly the endoplas-
mic reticulum. This distribution needs to be con¢rmed by
localizing endogenous protein. While abolishing the GTP
binding capability of the long form does not appear to alter
its distribution at the light microscopic level, the same is not
true of the short form. Mutant short eseptin expressed in COS
cells causes the protein to be localized in a more perinuclear
fashion. Mutant long eseptin did not have a dramatically
changed distribution. The short eseptin is comprised of the
central conserved domain and lacks carboxy- or amino-termi-
nal extensions, suggesting that it may have limited ability to
bind non-septin partners. Assuming that the signals for septin
assembly are contained within their central conserved region,
the short eseptin may be restricted to septin ¢laments, and the
GTP binding mutation may completely disrupt its ability to
assemble into these ¢laments. In the absence of other binding
Fig. 5. Localization of heterologously expressed eseptins. Myc epitope tagged eseptins were transfected into COS cells, and expressed protein
was detected using a monoclonal antibody to the myc epitope. Scale bar, 4 Wm.
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partners to stabilize or target the mutant short eseptin, it may
form intracellular aggregates. Future studies to identify the
functions of the two forms will help expand our understand-
ing of septins in general.
It has been shown recently that the septins associate with
the sec 6/8 complex [12]. The sec 6/8 complex is the mamma-
lian counterpart to the yeast exocyst. In yeast, the exocyst
plays a role both in the secretory pathway and during cyto-
kinesis [15]. Members of the sec 6/8 complex show homology
to components of the yeast exocyst, and the overall biophys-
ical characteristics of the sec 6/8 complex suggest that it prob-
ably has similar functions to that of the yeast complex [16]. It
has recently been shown that the sec 6/8 complex has a peri-
odic distribution in the growing axons of cultured hippocam-
pal neurons [17]. While the mechanism by which the complex
is selectively placed in these speci¢c sites is unknown, the
interaction between the complex and the septins may play a
role. A major question to be answered is whether septins form
a nucleation site on the plasma membrane about which the sec
6/8 complex localizes, or whether their association occurs at
earlier stages of sec 6/8 complex targeting within the cell.
Since septins have already been shown to localize several as-
sociated proteins to speci¢c sites on the plasma membrane
[2,4,18,19], it is tempting to postulate that the sec 6/8 complex
is another substrate for septin localization. One question is
how the septins can target such a variety of proteins with
no apparent homology to each other. There are now at least
eight characterized mammalian septins, ¢ve of which appear
to interact with the sec 6/8 complex. It is likely that the sub-
unit composition of septin ¢laments and the stoichiometry of
the individual septins within these ¢laments determine the
substrate speci¢city for targeting. Further studies of the septin
gene family are required to better understand the functions of
these proteins in processes as diverse as cytokinesis, exocyto-
sis, and the establishment of cell polarity.
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